1,814
Views
46
CrossRef citations to date
0
Altmetric
Research Article

Stereotactic body radiation therapy for abdominal targets using volumetric intensity modulated arc therapy with RapidArc: Feasibility and clinical preliminary results

, , , , , , , , & show all
Pages 528-538 | Received 21 Oct 2010, Accepted 21 Jan 2011, Published online: 21 Feb 2011

Figures & data

Table I. Main characteristics of patients cohort.

Figure 1. Examples of dose distributions for the four groups of patients. Colourwash scale is reported on the figure. Solid lines represents target volumes and organs at risk.

Figure 1. Examples of dose distributions for the four groups of patients. Colourwash scale is reported on the figure. Solid lines represents target volumes and organs at risk.

Figure 2. Average dose volume histograms for target volumes and healthy tissue for the abdominal metastases patients. Dashed lines represent the inter-patient variability at one standard deviation.

Figure 2. Average dose volume histograms for target volumes and healthy tissue for the abdominal metastases patients. Dashed lines represent the inter-patient variability at one standard deviation.

Figure 3. Average dose volume histograms for target volumes and healthy tissue for the pancreas patients.

Figure 3. Average dose volume histograms for target volumes and healthy tissue for the pancreas patients.

Figure 4. Average dose volume histograms for target volumes and liver for the hepatic patients treated at 45 Gy.

Figure 4. Average dose volume histograms for target volumes and liver for the hepatic patients treated at 45 Gy.

Figure 5. Average dose volume histograms for target volumes and liver for the hepatic patients treated at 75 Gy.

Figure 5. Average dose volume histograms for target volumes and liver for the hepatic patients treated at 75 Gy.

Table II. Main technical features of delivered treatments.

Table III. Summary of dose volume histogram analysis for CTV, PTV and healthy tissue.

Table IV. Summary of dose volume histogram analysis for organs at risk.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.